Ordinary Adjustment | Solactive Pharma Breakthrough Value Index | Effective Date 23rd September 2024
Solactive Pharma Breakthrough Value Index:
In the ordinary adjustment, the following composition will be implemented effective open 23rd September 2024:
| LG CHEM LTD |
| KYOWA KIRIN CO LTD |
| BRISTOL-MYERS SQUIBB CO |
| CHUGAI PHARMACEUTICAL CO LTD ORD |
| EISAI |
| JOHNSON & JOHNSON |
| NOVARTIS AG-SPONSORED ADR |
| TAKEDA PHARMACEUTICAL |
| LIGAND PHARMACEUTICALS INC |
| ASTRAZENECA PLC-SPONS ADR |
| VERTEX PHARMACEUTICALS INC |
| BIOGEN INC |
| GENMAB A/S |
| PHARMA MAR SA |
| IONIS PHARMACEUTICALS INC |
| BIOCRYST PHARMACEUTICALS INC |
| UNITED THERAPEUTICS CORP |
| CSL LTD ORD |
| BIOMARIN PHARMACEUTICAL INC |
| SWEDISH ORPHAN BIOVITRUM AB |
| IPSEN SA |
| NIPPON SHINYAKU CO LTD |
| ALNYLAM PHARMACEUTICALS INC |
| HALOZYME THERAPEUTICS INC |
| JAZZ PHARMACEUTICALS PLC |
| SAREPTA THERAPEUTICS INC |
| SUPERNUS PHARMACEUTICALS INC |
| ROYALTY PHARMA PLC- CL A |
| CATALYST PHARMACEUTICALS INC |
| JCR PHARMACEUTICALS CO LTD |
| AGIOS PHARMACEUTICALS INC |
| ARGENX SE – ADR |
| ULTRAGENYX PHARMACEUTICAL INC |
| XERIS BIOPHARMA HOLDINGS INC |
| BEIGENE LTD-ADR |
| IDORSIA LTD |
| INNOCARE PHARMA LTD |